Stockscreener 앱 받기
0.7093
10.55%
-0.0837
시간 외 거래:
.71
0.0007
+0.10%
Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스
NMAD Stock Price and Chart — NASDAQ:NMAD - TradingView
Price to book forward of Rani Therapeutics Holdings, Inc. – NASDAQ:RANI - TradingView
RANI Technical Analysis & Stock Price Forecast - Intellectia AI
RANI Stock Price, Quote & Chart - ChartMill
Rani Therapeutics | 8-K: Current report - Moomoo
Rani Therapeutics Appoints Nicholas Maestas as New Chief Financial Officer Effective June 29, 2026 - Minichart
New Rani Therapeutics (NASDAQ: RANI) CFO granted options, 2026 inducement plan - Stock Titan
Rani Therapeutics Holdings, Inc. Announces Appointment of Nicholas Maestas as Chief Financial Officer, Effective June 29, 2026 - marketscreener.com
Rani Therapeutics names Nicholas Maestas as CFO - Investing.com
Rani Therapeutics Names Nicholas Maestas CFO - Moomoo
Rani Therapeutics names Nicholas Maestas as CFO By Investing.com - Investing.com Australia
Press Release: Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer - Moomoo
Price to earnings forward of Rani Therapeutics Holdings, Inc. – NASDAQ:RANI - TradingView
Rani Therapeutics Holdings, Inc. Class A Actuals & Estimates (NASDAQ:RANI) - TradingView
RANI Forecast — Price Target — Prediction for 2027 - TradingView
Rani Therapeutics Holdings Inc (RANI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to sales forward of Rani Therapeutics Holdings, Inc. – NASDAQ:RANI - TradingView
Rani Therapeutics Holdings Inc (RANI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
RANI SEC FilingsRani Therapeutics Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Rani Therapeutics Holdings Inc (RANI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rani Therapeutics Holdings Inc (RANI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rani Therapeutics Holdings Inc (RANI) Institutional Confidence - TradingKey
Rani Therapeutics Holdings Inc (RANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rani Therapeutics Holdings Inc - TradingKey
Rani Therapeutics Holdings Inc (RANI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rani Therapeutics Holdings Inc (RANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
RANI Q1 2026 Earnings: Narrower Loss Drives Optimism Despite Stock PullbackGuidance Update - dars.gov.et
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
RANI Q1 2026 Earnings: Narrower-than-Expected Loss as Pipeline Development AdvancesNew Analyst Coverage - dars.gov.et
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Javadi Alireza - Moomoo
[Form 4] Rani Therapeutics Holdings, Inc. Insider Trading Activity - Stock Titan
Rani Therapeutics (RANI) grants CBO 805,500 stock options - Stock Titan
Rani Therapeutics (NASDAQ: RANI) CTO awarded 805,500 stock options - Stock Titan
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director IMRAN MIR A - Moomoo
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ausiello Dennis A - Moomoo
Director Abraham Bassan receives 123,600 Rani (RANI) stock options - Stock Titan
Rani Therapeutics (NASDAQ: RANI) director receives stock options on 123,600 shares - Stock Titan
Imran Mir A of Rani Therapeutics (NASDAQ: RANI) receives 123,600 stock options - Stock Titan
Director at Rani Therapeutics (RANI) receives 123,600 stock options as compensation award - Stock Titan
Rani Therapeutics (RANI) director granted 123,600 options at $0.9515 exercise price - Stock Titan
Rani Therapeutics (RANI) director receives 123,600 stock options at $0.9515 strike - Stock Titan
Rani Therapeutics Shareholders Back Board and Auditor at Meeting - TipRanks
Rani Therapeutics (RANI) stockholders elect directors and ratify 2026 auditor - Stock Titan
Akkaraju funds lift Rani Therapeutics (RANI) beneficial stake to 9.99% - Stock Titan
Rani Therapeutics to raise $20M in registered direct offering - MSN
Rani Therapeutics | 424B5: Prospectus - Moomoo
Rani Therapeutics Holdings, Inc. Announces Securities Purchase Agreement and Pre-Funded Warrant Offering – SEC 8-K Filing Details - Minichart
Rani Therapeutics (RANI) raises ~$19.99M via Class A shares and pre-funded warrants - Stock Titan
Rani Therapeutics to Raise ~$20M via $1.07 Share Offering and Pre-Funded Warrants - TradingView
Rani Therapeutics (RANI) prices $20M stock and pre-funded warrant sale - Stock Titan
RANI Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Positive Stock ReactionNew Analyst Coverage - dars.gov.et
Rani Therapeutics Prices Registered Direct Offering of 12.5 Million Shares - Moomoo
Rani Therapeutics prices $20M direct offering of Class A common stock at market price - Pluang
Rani Therapeutics raises $20 million in direct offering By Investing.com - Investing.com Nigeria
Rani Therapeutics raises $20 million in direct offering - Investing.com
1.17%
2.48%
자본화:
|
볼륨(24시간):